RIPK3 and diabetic cardiomyopathy: Recent studies have reported that in the myocardial tissue of high-glucose-driven diabetic cardiomyopathy mice undergoing CaMKII δ alternative splicing disorder, inhibiting RIPK3 can alleviate CaMKII δ dysfunction in cardiomyocytes [5, 14, 15].